Epigenetics Market: By Enzymes (DNA polymerase, Acetylases, DNA ligases, Methyltransferase, RNA ligases, Reverse Transcriptase, Others), By Instruments (Next generation sequencers, Mass spectrometers, Sonicators, qPCRs, Others), By Application (Oncology, Cardiovascular diseases, Metabolic diseases, Inflammatory diseases, Infectious diseases), By kits and Assays (Deep sequencing kit, Bisulfate conversion kit, Methyltransferase assays, Chip- seq kits, Immunoprecipitation kits, Histone assay), By End-User (Pharmaceutical and biotechnological companies, Contract research companies, Academic and Research Institutes), and Geography.


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Epigenetics Market Size was valued at US$ 823 Million in 2020 and is projected to reach US$ 2021.73 Million at a CAGR of 13.7% by 2027 during the forecast period 2021- 2027. Epigenetics is a study of heritable changes in gene expression which involves the change in phenotype without changing genotype, which in turn affects the reading of genes by cells. Epigenetic changes are natural and regular processes but also influenced by various factors like lifestyle, environment, age and state of disease. Epigenetic modifications can manifest a common manner of cells which differentiate terminally to end up as liver cells, skin cells, brain cells etc. Epigenetic change may have more damaging effects which can lead to diseases like cancer. Systems like histone modification, non-coding RNA-associated gene silencing and DNA methylation are considered for initiation of epigenetic change sustainably. In October 2016 Episode an epigenetics data company launched SEED a novel male fertility test to evaluate epigenetic changes on DNA to detect a risk of infertility and poor embryo development. In June 2011, Cayman chemical company has adopted Genedata screener of Genedata, the company of advanced software solutions for drug discovery and life science research as a data management platform for cayman’s new epigenetic screening laboratory.

Global Epigenetics Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Asia Pacific
Epigenetics Market Dynamics

The surge in the prevalence of cancer, improving funds and aids for the R&D activities, rise in the partnerships between pharmaceutical and biotechnology companies and research institutes, increase in epigenetics application in non-oncology diseases will propel the epigenetics. Moreover, improved advancements in epigenetics technology, untapped potential of emerging markets like India and China are expected to offer many opportunities for the growth of epigenetics market. However, high instrument cost and the dearth of skilled personnel are expected to hamper the growth of the market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Epigenetics Market Segmentation

  • DNA polymerase
  • Acetylases
  • DNA ligases
  • Methyltransferase
  • RNA ligases
  • Reverse Transcriptase
  • Others
  • Next generation sequencers
  • Mass spectrometers
  • Sonicators
  • qPCRs
  • Others
Application, End-Use
  • Oncology
  • Cardiovascular diseases
  • Metabolic diseases
  • Inflammatory diseases
  • Infectious diseases
  • Pharmaceutical and biotechnological companies
  • Contract research companies
  • Academic and Research Institutes
kits and Assays
  • Deep sequencing kit
  • Bisulfate conversion kit
  • Methyltransferase assays
  • Chip- seq kits
  • Immunoprecipitation kits
  • Histone assay

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • Illumina, Inc. (U.S.)
  • Abcam plc. (U.K)
  • QIAGEN N.V. (Netherland)
  • New England Biolabs, Inc. (U.S.)
  • Merck & Co. (U.S.)
  • Sigma-Aldrich Corporation (U.S.)
  • Genedata AG(Switzerland)
  • Cayman chemical company (U.S)
  • Active Motif (U.S.)
  • Thermo Fisher Scientific, Inc., (U.S.)
  • Diagenode, Inc. (Belgium)
  • Zymo Research Corporation (U.S.).
  • Episona Inc. (U.S).